fter becoming Director in 2005, Dr. Nabel oversaw an extensive national portfolio of research to prevent, diagnose, and treat heart, lung, and blood diseases.
Under her leadership, the Institute released a Strategic Plan to help guide NHLBI’s scientific directions over the next five to ten years. In addition, she continued and expanded the Institute’s commitment to professional, public, and patient education programs. A cardiologist with extensive clinical experience, Dr. Nabel made many contributions to basic and clinical research on the pathogenesis and treatment of cardiovascular diseases.
Dr. Nabel joined NHLBI in 1999 as the Institute’s Scientific Director of Clinical Research. Prior to coming to NHLBI, Dr. Nabel was Chief of the Division of Cardiology at the University of Michigan where she became known for her research in the molecular genetics of cardiovascular diseases and strategies for gene transfer to benefit patients with those diseases. At the NHLBI, her research focused on the role of genetic factors in blood vessel diseases. Dr. Nabel served as a Visiting Professor at major medical centers throughout the country and delivered major lectures in Europe and Australia. She received numerous awards for her scientific accomplishments and is a partner on 16 patents.
Dr. Nabel currently serves as the President of Brigham and Women's/Faulkner Hospitals in Boston.
Last Updated: May 6, 2016